Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMGN

ImmunoGen (IMGN) Stock Price, News & Analysis

ImmunoGen logo

About ImmunoGen Stock (NASDAQ:IMGN)

Advanced Chart

Key Stats

Today's Range
$31.23
$31.23
50-Day Range
$31.23
$31.23
52-Week Range
$3.61
$31.25
Volume
40 shs
Average Volume
8.78 million shs
Market Capitalization
$8.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoGen and its competitors with MarketBeat's FREE daily newsletter.

IMGN Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Artisan International Small-Mid Instl
See More Headlines

IMGN Stock Analysis - Frequently Asked Questions

ImmunoGen, Inc. (NASDAQ:IMGN) released its quarterly earnings data on Monday, July, 31st. The biotechnology company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.14. The firm's revenue for the quarter was up 485.9% compared to the same quarter last year.
Read the conference call transcript
.

ImmunoGen subsidiaries include Hurricane LLC, ImmunoGen BioPharma (Ireland) Limited, ImmunoGen Europe Limited, and ImmunoGen Securities Corp..

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmunoGen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), GE Aerospace (GE), Arista Networks (ANET) and Adobe (ADBE).

Company Calendar

Last Earnings
7/31/2023
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IMGN
CIK
855654
Employees
277
Year Founded
1981

Profitability

EPS (Trailing Twelve Months)
($0.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
390.38
P/E Growth
N/A
Net Income
-$222.93 million
Net Margins
-25.56%
Pretax Margin
-25.24%
Return on Equity
-22.11%
Return on Assets
-13.53%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
5.70
Quick Ratio
5.65

Sales & Book Value

Annual Sales
$287.61 million
Price / Sales
28.91
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
43.99

Miscellaneous

Outstanding Shares
266,264,000
Free Float
252,764,000
Market Cap
$8.32 billion
Optionable
Optionable
Beta
1.18

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:IMGN) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners